Results 71 to 80 of about 29,283 (148)

Interaktionen kardialer und antiretroviraler Medikation [PDF]

open access: yes, 2018
Zusammenfassung: Neue therapeutische Optionen der hochaktiven antiretroviralen Therapie (HAART) haben die Morbidität und Mortalität von HIV-infizierten Patienten deutlich gesenkt, so dass nun vermehrt die altersspezifischen Erkrankungen manifest werden ...
Drewe, Jürgen, Egger, Sabin
core  

Eletriptan in the management of acute migraine. An update on the evidence for efficacy, safety, and consistent response [PDF]

open access: yes, 2016
Migraine is a multifactorial, neurological and disabling disorder, also characterized by several autonomic symptoms. Triptans, selective serotonin 5-HT1B/1D agonists, are the first-line treatment option for moderate-to-severe headache attacks.
Capi, Matilde   +6 more
core   +1 more source

Cytochrome P450 inhibition potential of new psychoactive substances of the tryptamine class [PDF]

open access: yes, 2016
New psychoactive substances (NPS) are not tested for their cytochrome P450 (CYP) inhibition potential before consumption. Therefore, this potential was explored for tryptamine-derived NPS (TDNPS) including alpha-methyl tryptamines (AMTs), dimethyl ...
Brandt, SD   +4 more
core   +1 more source

Personalized prescribing: a new medical model for clinical implementation of psychotropic drugs. [PDF]

open access: yes, 2016
The use of pharmacogenetic tests was already being proposed in psychiatry in the early 2000s because genetic factors were known to influence drug pharmacokinetics and pharmacodynamics.
Eap, C.B.
core   +1 more source

Factors Influencing the Magnitude and Clinical Significance of Drug Interactions Between Azole Antifungals and Select Immunosuppressants [PDF]

open access: yes, 2006
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/90188/1/phco.26.12.1730 ...
Carver, Peggy L.   +2 more
core   +1 more source

Prevalence of cannabidiol use in persons with cystic fibrosis

open access: yes
Pediatric Pulmonology, Volume 59, Issue 12, Page 3790-3792, December 2024.
Emma M. Tillman   +4 more
wiley   +1 more source

Future of Pharmacogenetics in Cardiovascular Diseases [PDF]

open access: yes, 2012
Introduction: Pharmacogenetics is the study of variations in DNA sequence as related to drug response (European Medicines Agency [EMA], 2007). Several gene-drug interactions have been discovered in the field of cardiovascular diseases (CVDs). These gene-
de Boer, A   +7 more
core   +2 more sources

The Investigational Drug VT-1129 Is a Highly Potent Inhibitor of Cryptococcus Species CYP51 but Only Weakly Inhibits the Human Enzyme [PDF]

open access: yes, 2016
Cryptococcosis is a life-threatening disease often associated with HIV infection. Three Cryptococcus species CYP51 enzymes were purified and catalyzed the 14α-demethylation of lanosterol, eburicol, and obtusifoliol.
Garvey, Edward P.   +8 more
core   +1 more source

Poster Sessions

open access: yes
HemaSphere, Volume 9, Issue S1, June 2025.
wiley   +1 more source

Clopidogrel Pharmacogenetics, resistance to antiplatelet therapy in ischemic stroke by Epigenome Wide Association Study (EWAS). [PDF]

open access: yes, 2014
Curs 2012-2013Clopidogrel is a widely used antiplatelet drug used in preventing vascular events after suffering a first stoke. Genome-wide association studies (GWAS) has not been able to establish a clear association between polymorphisms and recurrence.
Gallego Fàbrega, Cristina
core  

Home - About - Disclaimer - Privacy